In vitro activity of kitasamycin against gram-positive cocci.
D000617:Aminoglycosides / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002512:Cephalothin / Q000494:pharmacology; D002981:Clindamycin / Q000494:pharmacology; D004009:Dicloxacillin / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D007783:Lactones / Q000494:pharmacology; D008911:Minocycline / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D013210:Staphylococcus / Q000187:drug effects*; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D013297:Streptococcus pyogenes / Q000187:drug effects*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D007783:Lactones; D002981:Clindamycin; D004917:Erythromycin; D004009:Dicloxacillin; D008911:Minocycline; D010400:Penicillin G; D002512:Cephalothin